Investor Relations | Newsroom

Corporate Profile

Biodesix is a leading data-driven diagnostic solutions company leveraging state of the art technologies with our proprietary artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. We strive to be a trusted partner that the world relies on for diagnostic solutions in lung disease by improving overall patient outcomes and lowering the overall healthcare cost by reducing the use of ineffective and unnecessary treatments and procedures.

Biodesix is covered by the following analysts:

TD Cowen
Lake Street
William Blair
Canaccord Genuity
Craig-Hallum
Scotiabank

Minimum 15 minutes delayed. Source: